Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Edesa Biotech, Inc. (EDSA) had Income from Continuous Operations of $-2.23M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-2.23M |
|
-- |
|
-- |
|
$2.47M |
|
$-2.47M |
|
$0.24M |
|
$-2.23M |
|
$-2.23M |
|
$-2.23M |
|
|
Income from Continuous Operations |
$-2.23M |
$-2.23M |
|
$-2.23M |
|
$-2.47M |
|
$-2.44M |
|
5.68M |
|
5.68M |
|
$-0.24 |
|
$-0.24 |
|
| Balance Sheet Financials | |
$11.51M |
|
-- |
|
$2.02M |
|
$13.53M |
|
$1.08M |
|
-- |
|
-- |
|
$1.08M |
|
$3.19M |
|
$10.47M |
|
$12.45M |
|
7.14M |
|
| Cash Flow Statement Financials | |
$-7.32M |
|
-- |
|
$17.03M |
|
$1.04M |
|
$10.79M |
|
$9.75M |
|
$0.73M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.32M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-69.82% |
|
-21.27% |
|
-16.47% |
|
-17.90% |
|
$1.74 |
|
$-1.29 |
|
$-1.29 |
|